← Back to Search

ASMAS for Asthma (PeerASMAS Trial)

N/A
Waitlist Available
Led By Glorisa Canino, PhD
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Awards & highlights

PeerASMAS Trial Summary

This trial will test a novel intervention - ASMAS - which is specifically designed to help Latino middle school children with asthma manage their condition. The intervention will be delivered by trained high school students who also have asthma, and the trial will take place in Providence, RI and San Juan, PR.

PeerASMAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in asthma control
Change in asthma related school absence ratio
Change in lung function
+1 more
Secondary outcome measures
Change in asthma Action plan/Inhaler availability
Change in asthma self-management
Change in child asthma knowledge
+1 more

PeerASMAS Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ASMASExperimental Treatment1 Intervention
ASMAS is an asthma self-management program based on NHLBI clinical guidelines for optimal school-based asthma management. It involves 4, 1½ hour sessions delivered in group format in the urban, middle school setting by a Latino High School Peer who has asthma. ASMAS focuses on asthma pathophysiology, symptom management, asthma medications, and trigger control.
Group II: Asthma education plus child healthActive Control1 Intervention
Asthma Education plus Child Health control condition will be delivered by an adult Health Educator , and includes 4 sessions (1 1/2 hrs long) of our existing asthma education ("Asthma's Magic Number") with added general health topics (nutrition, physical activity, safety).
Group III: No Treatment ControlActive Control1 Intervention
Students randomly assigned to this arm , will receive standard of care, which is no treatment, and will not participate in any group intervention sessions.

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
260 Previous Clinical Trials
71,302 Total Patients Enrolled
10 Trials studying Asthma
3,182 Patients Enrolled for Asthma
University of Puerto RicoOTHER
62 Previous Clinical Trials
20,398 Total Patients Enrolled
2 Trials studying Asthma
884 Patients Enrolled for Asthma
Glorisa Canino, PhDPrincipal InvestigatorUniversity of Puerto Rico
5 Previous Clinical Trials
1,222 Total Patients Enrolled
2 Trials studying Asthma
884 Patients Enrolled for Asthma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial allow those over forty to participate?

"The study's parameters require that those wishing to participate are between 11 and 14 years old. Subsequently, this yields 119 trials suitable for minors and 199 applicable clinical studies for seniors."

Answered by AI

Are enrollees being accepted at this time for the trial?

"This trial is still in the process of enrolling participants based on information from clinicaltrials.gov. It was initially posted on April 1st 2019 and edited for the last time October 21st 2020."

Answered by AI

How many individuals are currently enrolled in this trial?

"Yes, according to the clinicaltrials.gov records, this medical investigation is actively seeking participants. It was first posted on April 1st 2019 and most recently updated October 21th 2020, looking for 432 people over a single site."

Answered by AI

What is the primary goal of this research endeavor?

"The primary endpoint of this investigation, which will be monitored at baseline, after the intervention as well as 4, 8 and 12 months post-treatment is a change in symptom free days. Secondary objectives include an alteration in asthma self-management (via validated and reliable assessments for both child and caregiver), availability of rescue inhaler at school with an accompanying action plan according to reports from school nurses, plus modifications in child asthma self-efficacy based on scores registered using the Children's Asthma Self-Efficacy Scale (Cronbach alpha .87; Bursch et al., 1999). This tool comprises 14 items graded between 1"

Answered by AI

Is it possible for me to become involved in this research trial?

"Participants between the ages of 11 and 14 with a diagnosis of asthma are eligible for this trial, which aims to recruit 432 people in total."

Answered by AI
~72 spots leftby Apr 2025